How to Read HSV-2 Test Results and What They Mean

HSV-2 test results typically come back as either a blood antibody test with a numerical index value or a swab-based test that directly detects the virus. Understanding which test you received, and what the numbers on your report actually mean, matters because certain result ranges are notoriously unreliable. A “positive” HSV-2 blood test, for example, can be a false alarm depending on where the index value falls, and the timing of the test relative to possible exposure changes what you can trust about a negative result.

The Two Main Categories of HSV-2 Tests

Before making sense of any result, you need to know which kind of test was ordered. HSV testing falls into two broad camps: tests that look for the virus itself in a sore or affected area, and tests that look for antibodies in your blood. These answer fundamentally different questions. A swab test tells you whether an active lesion contains herpes virus right now. A blood test tells you whether your immune system has ever mounted a response to herpes, meaning you’ve been infected at some point.

Swab-based tests, especially those using PCR (polymerase chain reaction), are considered the most reliable way to confirm herpes when you have a visible sore. PCR is far more sensitive than the older method of growing the virus in a lab culture. In one study comparing the two approaches, PCR caught the virus in about 59% of patients tested, while culture caught it in only 48%, and PCR’s sensitivity was 100% compared to 50% for culture when only one method detected the virus in a given sample. PCR also returned results in less than a day on average, compared to about a week for culture.¹ Another study found similar results in genital samples specifically, with PCR detecting herpes in 59% of patients versus 48% by culture.²

Blood tests, on the other hand, are what most people encounter when they ask a doctor for herpes testing without having any visible symptoms. These are type-specific IgG antibody tests that can distinguish between HSV-1 and HSV-2. The most commonly used commercial versions are HerpeSelect and the DiaSorin Liaison assay. Your result will come back with an index value, a number that the lab uses to categorize your result as negative, equivocal, or positive. And that number deserves a closer look.

What the Index Value on Your Blood Test Means

If you received a type-specific IgG blood test for HSV-2, your results sheet will show an index value, sometimes called a signal-to-cutoff ratio. The standard interpretation is straightforward on the surface:

Below 0.90: Negative. No antibodies detected.
0.90 to 1.09: Equivocal. The test can’t decide. Retesting in a few weeks is recommended.
1.10 and above: Positive. Antibodies detected.

This is where most lab reports stop explaining, and where the trouble begins. A result of 1.10 is treated the same as a result of 8.0 on the report, but those two numbers carry very different levels of confidence. The zone between roughly 1.10 and 3.50 is plagued by false positives, meaning the test says you have HSV-2 antibodies when you actually don’t.

How bad is the problem? In a study evaluating the DiaSorin Liaison HSV-2 IgG assay, about 21% of positive results with index values below 3.0 turned out to be false positives.³ CDC guidelines have long recommended confirmatory testing for results in the low-positive range of 1.10 to 3.50 on the HerpeSelect assay. But even that cutoff misses some false positives: one analysis found that 20% of confirmed false-positive results on HerpeSelect, and 39% on the Liaison assay, had index values above 3.50.⁴ In other words, the low-positive zone is clearly unreliable, but even values above 3.50 aren’t bulletproof.

As a practical rule: the higher your index value, the more confident you can be that it’s a true positive. Values above 5.0 are rarely false. Values between 1.10 and 3.50 should always be confirmed before you accept the diagnosis. And if your result falls in that low-positive zone and you have no symptoms and no known exposure, the odds of a false positive go up further, because the test performs worse in populations where HSV-2 is less common.

Why False Positives Happen

The type-specific IgG tests for HSV-2 work by detecting antibodies to a particular protein on the virus called glycoprotein G2 (gG2). In theory, this protein is unique enough to distinguish HSV-2 from HSV-1. In practice, cross-reactivity from other infections can muddy the water. Cross-reactivity from other herpesviruses and unrelated pathogens has been documented, occurring at rates around 9% for HerpeSelect and under 1% for DiaSorin.⁵

HSV-1 antibodies themselves may also play a role. Research has found that very high levels of HSV-1 IgG can interfere with the confirmation process for HSV-2, creating ambiguous “indeterminate” results. The median HSV-1 IgG index values in the HSV-2 indeterminate group were significantly higher than in both the confirmed false-positive and confirmed true-positive groups, suggesting that abundant HSV-1 antibodies can create a complex that interferes with the assay’s ability to detect genuine HSV-2 antibodies.⁵ So if you already carry HSV-1 (which the majority of the global population does), that can complicate your HSV-2 blood test interpretation.

What Confirmatory Testing Looks Like

If you get a positive HSV-2 IgG result and either the index value is low-positive or the clinical picture doesn’t fit, your provider may order a confirmatory test. The gold standard for confirmation has historically been the HSV Western blot, developed at the University of Washington. This test is more labor-intensive and less widely available, but it’s considerably more accurate.

In one study of men at a sexually transmitted disease clinic who had tested positive on the HerpeSelect ELISA, 84% were confirmed positive by Western blot.⁶ That means about 16% of positive screening results in that group were not confirmed, a meaningful false-positive rate even in a higher-risk clinic population. Another confirmation option is the HSV-2 IgG inhibition assay, sometimes called the Biokit supplemental test, which checks whether the antibodies in your blood specifically bind to gG2 protein. This test is easier to access than the Western blot and serves a similar function.

The key takeaway: a single positive IgG screening test, especially in the low-positive range, is not enough to diagnose HSV-2 with confidence. Confirmatory testing is a reasonable and often important next step.

Skip the IgM Test

You may come across HSV IgM testing, either because a provider ordered it or because it appeared on a panel of tests. IgM antibodies are produced early in an infection, so the idea behind IgM testing is to catch a recent or new infection. In practice, HSV IgM tests are unreliable, can’t distinguish between HSV-1 and HSV-2, and are not recommended by any major guidelines for diagnosing genital herpes.

The problems go beyond theoretical concerns. A study of COVID-19 patients found that 45% tested positive for HSV IgM on one commonly used platform (the Liaison assay), despite having no evidence of active herpes. None of those same samples tested positive on a different assay platform, pointing to immunoassay interference rather than true HSV reactivation.⁷ If nearly half of patients with a completely unrelated viral infection can trigger a false HSV IgM result, the test cannot be trusted for clinical decisions. If your result sheet shows only an IgM result, it tells you essentially nothing useful about your HSV-2 status.

The Window Period and When to Test

IgG antibody tests detect your immune system’s response to the virus, and that response takes time to develop. If you were recently exposed and test too soon, a negative IgG result may simply mean your body hasn’t produced detectable antibodies yet. This delay is called the seroconversion window.

A study tracking people with newly acquired herpes found that the median time from symptom onset to seroconversion was about 21 days on the HerpeSelect HSV-2 ELISA, and 40 to 47 days on the Western blot.⁸ Most guidelines suggest waiting at least 12 weeks after a suspected exposure before trusting a negative IgG result. Testing earlier can produce a negative that flips to positive later.

Antiviral medication may extend this window further. Research has found that people treated with acyclovir during their first herpes outbreak took significantly longer to develop antibodies to certain viral proteins. The mean time to seroconversion to one key glycoprotein was 39 days for acyclovir recipients compared to about 23 days for those on placebo.⁹ If you started antivirals right away during a first episode, keep in mind that your blood test may stay negative a bit longer than usual.

Why Routine Screening Is Not Recommended

This surprises many people: the US Preventive Services Task Force explicitly recommends against routine blood testing for genital herpes in people without symptoms. The reasoning isn’t that HSV-2 doesn’t matter. It’s that the available blood tests aren’t accurate enough when applied broadly. When you screen a low-risk population, the proportion of false positives climbs because fewer people actually have the infection. The USPSTF has reaffirmed that the high rate of false-positive results with gG2-based serologic tests in low-prevalence populations, combined with the psychological harms of an incorrect diagnosis and the absence of proven benefit in altering outcomes for asymptomatic people, makes routine screening a net negative.¹⁰

This doesn’t mean you can’t request testing. It means that if you have no symptoms and no known exposure, a positive blood test is more likely to be wrong than it would be for someone with a suspicious sore, and you should weigh that before deciding to test. If you do have symptoms, a swab PCR test during an outbreak is far more informative.

What a True Positive Means for Viral Shedding

If your result is confirmed positive, the natural question is what that means for your body day to day. HSV-2 establishes a lifelong infection, and the virus periodically reactivates and reaches the skin surface, sometimes producing visible sores and sometimes not. The episodes without visible symptoms are called subclinical shedding, and they’re responsible for the majority of herpes transmission.

A large study measuring daily genital swabs found that people with symptomatic HSV-2 shed virus on about 20% of days, while those with asymptomatic infection shed on about 10% of days. Even during subclinical shedding specifically (when no lesion was present), the rates were higher in people who had experienced symptoms: about 13% of days versus about 9% in those who had never noticed an outbreak. The amount of virus shed during those subclinical episodes, however, was similar between the two groups.¹¹ That last finding is the important one: even if you’ve never had a noticeable outbreak, the virus can still reach the surface and potentially be passed to a partner, and the viral load during those episodes is no different from what someone with symptoms produces.

Reducing Transmission After a Positive Result

A confirmed HSV-2 diagnosis opens up practical decisions about reducing the chance of passing the virus to a partner. Two tools have strong evidence behind them: daily antiviral therapy and condoms.

In the landmark trial of daily valacyclovir for transmission prevention, the drug cut the rate of symptomatic HSV-2 infection in uninfected partners by 75%, and reduced overall HSV-2 acquisition (including asymptomatic cases) by about 48%.¹² Separately, a study of people seropositive for HSV-2 who had never had noticeable outbreaks found that valacyclovir reduced subclinical shedding by about 71% compared to placebo.¹³

Condom use adds another layer of protection, though the benefit depends on the direction of transmission. One large study of discordant couples found that condoms reduced per-act transmission from men to women by 96%, a striking level of protection. Protection from women to men was lower, at about 65%, though that estimate didn’t quite reach statistical significance.¹⁴ The combination of daily antivirals, condoms, and avoiding sex during active outbreaks is the standard recommendation for minimizing risk in discordant couples.

HSV-1 Versus HSV-2 in Genital Herpes

Your test result will specify which type of herpes antibodies were detected. If you tested positive for HSV-1 only, that can still represent genital herpes (HSV-1 is now a common cause of genital infections, typically acquired through oral sex), but the clinical behavior is quite different from HSV-2. HSV-1 genital infections tend to recur far less often and involve less viral shedding over time.

Research tracking genital HSV-1 shedding found that rates declined substantially over the first year after initial infection and were lower than genital HSV-2 shedding rates at every time point measured. For context, genital HSV-2 shedding has been measured at about 34% of days in the first year after first episode and persists at roughly 17% of days even a decade later.¹⁵ If your blood test shows HSV-1 positive and HSV-2 negative, and your concern is genital herpes, the picture is generally more favorable in terms of recurrence and transmission risk than it would be with HSV-2.

Pregnancy and HSV-2 Testing

Pregnancy is one context where HSV-2 test results carry higher stakes. Neonatal herpes, though rare, can be severe. The greatest risk to a newborn comes from a mother acquiring a new HSV infection during the second half of pregnancy, because she won’t yet have developed the antibodies that help protect the baby during delivery.¹⁶

For this reason, some providers will order type-specific serology in pregnant patients or their partners to assess whether a woman might be at risk for a new acquisition during pregnancy. If you’re HSV-2 negative but your partner is positive, knowing that serostatus allows your care team to advise on precautions. If you’re already seropositive for HSV-2 before pregnancy, the risk to the baby is much lower because your existing antibodies cross the placenta and offer some protection. Active outbreaks near the time of delivery are typically managed with antiviral therapy and, if lesions are present, cesarean delivery.

The HSV-2 and HIV Connection

An HSV-2 positive result also carries implications for HIV risk. HSV-2 increases susceptibility to HIV, and this isn’t just an epidemiological correlation. Laboratory research using human cervical tissue has shown that HSV-2 infection increases the expression of receptors that HIV uses to enter cells, specifically CD4, CCR5, and CD38, and that co-infection with both viruses leads to enhanced HIV replication compared to HIV alone.¹⁷ For people who know they’re HSV-2 positive and are at risk for HIV exposure, this is worth discussing with a healthcare provider, since it may influence decisions about HIV prevention strategies.

The Emotional Side of a Positive Result

The psychosocial research on HSV-2 diagnosis is genuinely worth knowing about, because the emotional response to a positive result is often far more distressing than the infection itself. Qualitative studies of people diagnosed with HSV-2 by blood test have documented a cascade of reactions including distress, confusion, fear of telling partners, feeling “damaged goods,” and concern about future relationships.¹⁸

Interestingly, though, the intensity of these reactions tends to diminish with time and context. A study that followed people with no history of genital herpes who were newly tested found that those who received a positive HSV-2 result showed a decline in positive sexual attitudes at one week, but that difference had disappeared by three months. There was no significant change in overall mental health scores at any follow-up point. Perhaps most striking, people who were already HSV-2 positive viewed having genital herpes as significantly less traumatic than people who were HSV-2 negative imagined it would be.¹⁹ The gap between the anticipated devastation and the lived reality tends to close once people get accurate information and time to adjust. If you’ve just received a positive result and feel overwhelmed, that reaction is normal, well-documented, and likely to ease considerably.